Intensity Therapeutics, Inc. Common stock Strategic Asset Allocation Index
Intensity Therapeutics, Inc. Common stock strategic asset allocation index. Intensity Therapeutics, Inc. Common stock (INTS) has a Strategic Asset Allocation Index of 3.3% as of December 2019. Strategic assets (PP&E of $252.67K plus long-term investments of $-) total $252.67K, measured against net assets of $7.70 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See INTS net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Intensity Therapeutics, Inc. Common stock (2019–2019)
Strategic asset allocation index of Intensity Therapeutics, Inc. Common stock from 2019 to 2019. This chart shows how Intensity Therapeutics, Inc. Common stock's Strategic Asset Allocation Index has evolved across 1 annual periods from 2019 to 2019. As of December 2019, the index stands at 3.3%, representing strategic assets of $252.67K against net assets of $7.70 Million USD. Check INTS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Intensity Therapeutics, Inc. Common stock Strategic Asset Allocation Index by Year (2019–2019)
Intensity Therapeutics, Inc. Common stock strategic asset allocation index by year from 2019 to 2019. The table below presents the year-by-year Strategic Asset Allocation Index for Intensity Therapeutics, Inc. Common stock from 2019 to 2019, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see INTS stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 3.3% | $252.67K | $252.67K | $- | $7.70 Million | — |